Precigen, Inc. (PGEN)
4.38
+0.09
(+2.10%)
USD |
NASDAQ |
Nov 18, 11:53
Precigen Price to Book Value : 18.74 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 18.36 |
| November 16, 2026 | 18.40 |
| November 13, 2026 | 19.43 |
| November 12, 2026 | 19.94 |
| November 11, 2026 | 20.20 |
| November 10, 2026 | 19.34 |
| November 09, 2026 | 20.24 |
| November 06, 2026 | 19.13 |
| November 05, 2026 | 18.06 |
| November 04, 2026 | 21.63 |
| November 03, 2026 | 22.46 |
| November 02, 2026 | 21.99 |
| October 30, 2026 | 29.69 |
| October 29, 2026 | 28.41 |
| October 28, 2026 | 26.02 |
| October 27, 2026 | 26.31 |
| October 26, 2026 | 25.84 |
| October 23, 2026 | 26.49 |
| October 22, 2026 | 27.34 |
| October 21, 2026 | 28.24 |
| October 20, 2026 | 29.22 |
| October 19, 2026 | 28.50 |
| October 16, 2026 | 27.32 |
| October 15, 2026 | 30.79 |
| October 14, 2026 | 31.47 |
| Date | Value |
|---|---|
| October 13, 2026 | 32.01 |
| October 12, 2026 | 32.78 |
| October 09, 2026 | 33.42 |
| October 08, 2026 | 32.52 |
| October 07, 2026 | 32.26 |
| October 06, 2026 | 32.30 |
| October 05, 2026 | 33.12 |
| October 02, 2026 | 36.54 |
| October 01, 2026 | 35.13 |
| September 30, 2026 | 36.63 |
| September 29, 2026 | 66.14 |
| September 28, 2026 | 64.16 |
| September 25, 2026 | 63.67 |
| September 24, 2026 | 63.26 |
| September 23, 2026 | 61.12 |
| September 22, 2026 | 64.82 |
| September 21, 2026 | 63.26 |
| September 18, 2026 | 63.92 |
| September 17, 2026 | 64.66 |
| September 16, 2026 | 61.08 |
| September 15, 2026 | 57.51 |
| September 14, 2026 | 56.28 |
| September 11, 2026 | 56.28 |
| September 10, 2026 | 54.88 |
| September 09, 2026 | 55.87 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 1.292 |
| Aldeyra Therapeutics, Inc. | 1.149 |
| Repligen Corp. | 4.601 |
| AC Immune SA | 4.346 |
| Inovio Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PE Ratio | 98.21 |
| PS Ratio | 10.77 |
| Price | 4.38 |
| Earnings Yield | 1.02% |
| Market Cap | 1.570B |
| Operating PE Ratio | 50.24 |
| Normalized PE Ratio | 98.21 |